Mustang Bio, Inc. (MBIO)
NASDAQ: MBIO · Real-Time Price · USD
0.209
-0.012 (-5.30%)
Nov 20, 2024, 4:00 PM EST - Market closed
Mustang Bio Employees
Mustang Bio had 80 employees as of December 31, 2023. The number of employees decreased by 33 or -29.20% compared to the previous year.
Employees
80
Change (1Y)
-33
Growth (1Y)
-29.20%
Revenue / Employee
n/a
Profits / Employee
-$292,700
Market Cap
7.77M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
ATI Physical Therapy | 6,000 |
XWELL | 337 |
IM Cannabis | 95 |
Vincerx Pharma | 42 |
Vaccinex | 40 |
NeuroMetrix | 26 |
Virax Biolabs Group | 17 |
Galecto | 13 |
MBIO News
- 8 days ago - Mustang Bio Receives Positive Listing Determination from Nasdaq - GlobeNewsWire
- 13 days ago - Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma - GlobeNewsWire
- 27 days ago - Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds - GlobeNewsWire
- 5 months ago - Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB) - GlobeNewsWire
- 5 months ago - Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 5 months ago - Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 5 months ago - Why are Mustang Bio shares (MBIO) up almost 500%? - Invezz
- 5 months ago - Why Is Penny Stock Mustang Bio Trading Over 190% On Monday? - Benzinga